Unleashing the tiger – iatrogenic autoimmunity from cancer immunotherapy drugs

Immune checkpoint inhibitors can lead to the development of organ and non-organ specific immune related adverse events.

Detalles Bibliográficos
Autores principales: Luu, Queenie, Major, Gabor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761926/
https://www.ncbi.nlm.nih.gov/pubmed/29344404
http://dx.doi.org/10.1177/2054270417746905